Evidence map›Paper›PMID 37385287›Full record

ArticleThe lancet. Diabetes & endocrinology2023

Rare variants in the MECP2 gene in girls with central precocious puberty: a translational cohort study.

Ana P M Canton, Flávia R Tinano, Leonardo Guasti, Luciana R Montenegro, Fiona Ryan, Deborah Shears, Maria Edna de Melo, Larissa G Gomes, Mariana P Piana, Raja Brauner and 20 more

Open access · greenAbstract read
In one paragraph

Article in The lancet. Diabetes & endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Journal of the Endocrine Society · 2026
    Article
  5. Review
  6. MECP2 Rare Variants in Boys With Central Precocious Puberty.The Journal of clinical endocrinology and metabolism · 2026
    Article
  7. Article
  8. Pubertal development is unaffected in femalemicroPublication biology · 2026
    Article
  9. Article
  10. Genetic and Epigenetic Contributions to Central Precocious Puberty.The Journal of clinical endocrinology and metabolism · 2025
    Article
  11. Article
  12. Environmental factors trigger pubertal development.Current opinion in pediatrics · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Disorders of puberty and neurodevelopment: A shared etiology?Annals of the New York Academy of Sciences · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 13 institutions in 5 countries.

Ana P M CantonDevelopmental Endocrinology Unit, Laboratory of Hormones and Molecular Genetics LIM/42, University of Sao Paulo, Sao Paulo, Brazil.
Flávia R TinanoDevelopmental Endocrinology Unit, Laboratory of Hormones and Molecular Genetics LIM/42, University of Sao Paulo, Sao Paulo, Brazil.
Leonardo GuastiCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Luciana R MontenegroDevelopmental Endocrinology Unit, Laboratory of Hormones and Molecular Genetics LIM/42, University of Sao Paulo, Sao Paulo, Brazil.
Fiona RyanOxford Children's Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Deborah ShearsOxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Maria Edna de MeloLeague of Childhood Obesity, University of Sao Paulo, Sao Paulo, Brazil.
Larissa G GomesDevelopmental Endocrinology Unit, Laboratory of Hormones and Molecular Genetics LIM/42, University of Sao Paulo, Sao Paulo, Brazil.
Mariana P PianaChildren's State Hospital of Vila Velha, Vila Velha, Brazil.
Raja BraunerFondation Ophtalmologique Adolphe de Rothschild and Université de Paris, Paris, France.
Rafael Espino-AguilarHospital Universitario Virgen de Valmes, Universidad de Sevilla, Sevilla, Spain.
Arancha Escribano-MuñozEndocrinology Unit, Department of Pediatrics, Virgen de la Arrixaca University Hospital, Murcia, Spain.
Alyssa PaganoniCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Jordan E ReadCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Márta KorbonitsCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Carlos E SeraphimDevelopmental Endocrinology Unit, Laboratory of Hormones and Molecular Genetics LIM/42, University of Sao Paulo, Sao Paulo, Brazil.
Silvia S CostaDiscipline of Endocrinology and Metabolism, Clinicas Hospital, School of Medicine and Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of Sao Paulo, Sao Paulo, Brazil.
Ana Cristina KrepischiDiscipline of Endocrinology and Metabolism, Clinicas Hospital, School of Medicine and Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of Sao Paulo, Sao Paulo, Brazil.
Alexander A L JorgeGenetic Endocrinology Unit LIM/25, University of Sao Paulo, Sao Paulo, Brazil.
Alessia DavidCentre for Integrative Systems Biology and Bioinformatics, Department of Life Sciences, Imperial College London, London, UK.
Lena R KaisingerMedical Research Council Epidemiology Unit, Wellcome-Medical Research Council Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, UK.
Ken K OngMedical Research Council Epidemiology Unit, Wellcome-Medical Research Council Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, UK.
John R B PerryMedical Research Council Epidemiology Unit, Wellcome-Medical Research Council Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, UK.
Ana Paula AbreuDivision of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Ursula B KaiserDivision of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Jesús ArgenteDepartment of Pediatrics, Universidad Autónoma de Madrid, Madrid, Spain; Department of Pediatrics and Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, IMDEA Food Institute, Madrid, Spain.
Berenice B MendoncaDevelopmental Endocrinology Unit, Laboratory of Hormones and Molecular Genetics LIM/42, University of Sao Paulo, Sao Paulo, Brazil.
Vinicius N BritoDevelopmental Endocrinology Unit, Laboratory of Hormones and Molecular Genetics LIM/42, University of Sao Paulo, Sao Paulo, Brazil.
Sasha R HowardCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Department of Paediatric Endocrinology, Barts Health NHS Trust, London, UK.
Ana Claudia LatronicoDevelopmental Endocrinology Unit, Laboratory of Hormones and Molecular Genetics LIM/42, University of Sao Paulo, Sao Paulo, Brazil. Electronic address: anacl@usp.br.
Universidade de São Paulo · BRMedical Research Council · GBBrigham and Women's Hospital · USOxford University Hospitals NHS Trust · GBQueen Mary University of London · GBWilliam Harvey Research Institute · GBBarts Health NHS Trust · GBFondation Ophtalmologique Adolphe de Rothschild · FRHospital Universitario Virgen de la Arrixaca · ESImperial College London · GBUniversidad Autónoma de Madrid · ESUniversidad de Sevilla · ESUniversidade Vila Velha · BR

Funding

Deciphering the functional role of MKRN3 in puberty and reproductionR01HD082314 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI Ursula B. Kaiser · 2015 to 2026
$5.7M
MKRN3 imprinting, regulation, and action in the control of pubertyR00HD091381 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI METZGER, ANA PAULA DE ABREU E SILVA · 2019 to 2021
$746k
Integrated analysis of genetic and epigenetic variants in central precocious pubertyR21HD098684 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI KAISER, URSULA B. · 2020 to 2021
$492k
Medical Research Council MC_UU_00006/2NICHD NIH HHS R00 HD091381NICHD NIH HHS R01 HD082314NICHD NIH HHS R21 HD098684Wellcome Trust
6 · The paper itself

Abstract

backgroundIdentification of genetic causes of central precocious puberty have revealed epigenetic mechanisms as regulators of human pubertal timing. MECP2, an X-linked gene, encodes a chromatin-associated protein with a role in gene transcription. MECP2 loss-of-function mutations usually cause Rett syndrome, a severe neurodevelopmental disorder. Early pubertal development has been shown in several patients with Rett syndrome. The aim of this study was to explore whether MECP2 variants are associated with an idiopathic central precocious puberty phenotype.

methodsIn this translational cohort study, participants were recruited from seven tertiary centres from five countries (Brazil, Spain, France, the USA, and the UK). Patients with idiopathic central precocious puberty were investigated for rare potentially damaging variants in the MECP2 gene, to assess whether MECP2 might contribute to the cause of central precocious puberty. Inclusion criteria were the development of progressive pubertal signs (Tanner stage 2) before the age of 8 years in girls and 9 years in boys and basal or GnRH-stimulated LH pubertal concentrations. Exclusion criteria were the diagnosis of peripheral precocious puberty and the presence of any recognised cause of central precocious puberty (CNS lesions, known monogenic causes, genetic syndromes, or early exposure to sex steroids). All patients included were followed up at the outpatient clinics of participating academic centres. We used high-throughput sequencing in 133 patients and Sanger sequencing of MECP2 in an additional 271 patients. Hypothalamic expression of Mecp2 and colocalisation with GnRH neurons were determined in mice to show expression of Mecp2 in key nuclei related to pubertal timing regulation.

findingsBetween Jun 15, 2020, and Jun 15, 2022, 404 patients with idiopathic central precocious puberty (383 [95%] girls and 21 [5%] boys; 261 [65%] sporadic cases and 143 [35%] familial cases from 134 unrelated families) were enrolled and assessed. We identified three rare heterozygous likely damaging coding variants in MECP2 in five girls: a de novo missense variant (Arg97Cys) in two monozygotic twin sisters with central precocious puberty and microcephaly; a de novo missense variant (Ser176Arg) in one girl with sporadic central precocious puberty, obesity, and autism; and an insertion (Ala6_Ala8dup) in two unrelated girls with sporadic central precocious puberty. Additionally, we identified one rare heterozygous 3'UTR MECP2 insertion (36_37insT) in two unrelated girls with sporadic central precocious puberty. None of them manifested Rett syndrome. Mecp2 protein colocalised with GnRH expression in hypothalamic nuclei responsible for GnRH regulation in mice.

interpretationWe identified rare MECP2 variants in girls with central precocious puberty, with or without mild neurodevelopmental abnormalities. MECP2 might have a role in the hypothalamic control of human pubertal timing, adding to the evidence of involvement of epigenetic and genetic mechanisms in this crucial biological process.

fundingFundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico, and the Wellcome Trust.

Indexed as

Puberty, PrecociousRett SyndromeAnimalsBrazilChildCohort StudiesFemaleFollicle Stimulating HormoneGonadotropin-Releasing HormoneHumansLuteinizing HormoneMaleMethyl-CpG-Binding Protein 2MiceFollicle Stimulating HormoneGonadotropin-Releasing HormoneLuteinizing HormoneMECP2 protein, humanMethyl-CpG-Binding Protein 2

Identifiers

PMID37385287
PMCPMC7615084
OpenAlexW4382051871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.